CROClinical Trials Market

A CRO (Contract Research Organization) is a company that provides clinical trial management services for the pharmaceutical, biotech, and medical device industries.

Although there are different types of CROs and diverse levels of specialization (distinct therapeutic areas for instance), typical CRO services include regulatory affairs, site selection and activation, recruitment support, clinical monitoring, data management, trial logistics, pharmacovigilance, biostatistics, medical writing, and project management, among others.

In a clinical trial, CROs are hired by sponsors to perform a set of tasks, taking various technical and administrative responsibilities on the sponsor?s behalf. The main role of the CRO is to plan, coordinate, execute, and supervise the processes involved in the development of a clinical trial, being a central contact point between the sponsor and other trial actors (e.g. ethics committees, regulatory agencies, vendors, and hospitals).

CROClinical Trials Market contains market size and forecasts of CRO in Clinical Trials in Global, including the following market information:

Global CRO in Clinical Trials Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global CRO in Clinical Trials market was valued at 65750 million in 2021 and is projected to reach US$ 117610 million by 2028, at a CAGR of 8.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Phase I Trial Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of CRO in Clinical Trials include Labcorp, IQVIA, Parexel, Syneos Health, PRA Health Sciences, PPD, ICON, MedPace and Wuxi AppTec. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the CRO in Clinical Trials companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global CRO in Clinical Trials Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global CRO in Clinical Trials Market Segment Percentages, by Type, 2021 (%)

Phase I Trial

Phase II Trial

Phase III Trial

Phase IV Trial

Global CRO in Clinical Trials Market, by End User, 2017-2022, 2023-2028 ($ millions)

Global CRO in Clinical Trials Market Segment Percentages, by End User, 2021 (%)

Pharmaceutical

Bio-pharm

Others

Global CRO in Clinical Trials Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global CRO in Clinical Trials Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies CRO in Clinical Trials revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies CRO in Clinical Trials revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Labcorp

IQVIA

Parexel

Syneos Health

PRA Health Sciences

PPD

ICON

MedPace

Wuxi AppTec